Wed.Jun 19, 2024

article thumbnail

How to Improve Medication Adherence Within the Pharmacy

Drug Topics

Medication nonadherence can account for up to 50% of treatment failures and over $500 billion in annual health care costs.

201
201
article thumbnail

Speaking a Second Language Has Countless Benefits in the Pharmacy Setting

Pharmacy Times

Being able to communicate in a different language can improve treatment adherence and medication efficacy outcomes

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Substance use experts are sounding the alarm on another addiction: gambling

STAT

LAS VEGAS — Downstairs was a sensory overload: Roulette wheels spun, slot-machine chimes rang, and dealers hurried to scoop up stacks of casino chips resting in front of busted blackjack hands. Many gamblers held a drink in one hand and a cigarette in the other.  It was perhaps a strange setting for a conference about substance use treatment.

144
144
article thumbnail

Expert: Maternal Health Disparities, Role of Pharmacists in Improving Outcomes

Pharmacy Times

Reducing maternal mortality through improving access, screening, education and providing support during pregnancy.

139
139
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How a Baltimore neuroscience study is rewriting Black America’s relationship with medical research

STAT

Priscilla Agnew-Hines will never be able to forget that day in early 2020. On March 26, just weeks after Covid-19 officially became a global pandemic, her son died from an overdose. Larry, 41, was a chef, a drummer for his gospel church and the son who challenged Priscilla’s barbecue skills during summer cookouts. He also struggled with addiction.

143
143
article thumbnail

Educate Patients About Cough and Cold Product Ingredients

Pharmacy Times

Read the Drug Facts Label to Learn More About OTC Medications.

Labelling 132

More Trending

article thumbnail

GLP-1s Lead to Weight Loss, Improved CVD Outcomes in Breast Cancer

Drug Topics

In 2 abstracts presented at ASCO 2024, researchers addressed the use of GLP-1s for weight loss and to reduce cardiovascular outcomes in women with breast cancer.

131
131
article thumbnail

STAT+: New study bolsters evidence rare genetic mutation can delay early Alzheimer’s

STAT

For members of a large extended Colombian family, an early Alzheimer’s diagnosis is practically a grim guarantee. But new research further supports the idea that a rare genetic mutation can delay the devastating disease’s onset. An international team of researchers identified 27 individuals within this extended family who carried both a genetic variant that guaranteed they’d develop Alzheimer’s and a single copy of the so-called Christchurch mutation.

140
140
article thumbnail

Blood test could spot Parkinson’s years earlier

pharmaphorum

An AI-powered blood test that may be able to predict Parkinson’s years before symptoms develop could allow earlier treatment and guide trials of new treatments

128
128
article thumbnail

Opinion: It’s been 60 years since Freedom Summer, yet the fight for affordable, compassionate, and equitable health care is still going on

STAT

Sixty years ago this month, a courageous initiative created by civil rights activists and physicians aimed to transform the social and medical landscape of the United States by challenging segregation in the South. Called Freedom Summer, the work it began is still going on today. In 1964, Dr. Robert Smith , an architect of the U.S. community health center model, called activist Dr.

132
132
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

The Chemotherapist

Pharmacy Times

A pharmacist examines the intersection of medicine and humanity.

123
123
article thumbnail

STAT+: Novant Health calls off North Carolina hospital deal, giving a win to the FTC

STAT

Just two weeks ago, it appeared Novant Health was on the precipice of finalizing a deal to acquire two hospitals north of Charlotte, even though federal antitrust regulators, North Carolina officials, and economists were worried the deal would give Novant near-monopoly power in the region. But Novant, a nonprofit hospital system with $8 billion of revenue, decided to call off the deal mere hours after a federal court of appeals temporarily prevented Novant from buying the hospitals until the Fed

Hospitals 128
article thumbnail

Workplace Flexibility Could Increase Quality of Life, Productivity for Pharmacy Employees

Drug Topics

A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.

article thumbnail

How data is critical to commercialising drugs for rare diseases

pharmaphorum

Discover the importance of data in the process of commercialising drugs for rare diseases and how it plays a critical role in advancing treatment options for patients. Learn more about orphan diseases and drug development.

118
118
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment

Pharmafile

Assembly Biosciences has announced that the first participant has been dosed in its phase 1b trial of ABI-4334, the company’s next-generation capsid assembly modulator (CAM) candidate currently being developed for the treatment of chronic hepatitis B virus (HBV) infection. The post First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment appeared first on Pharmafile.

116
116
article thumbnail

Maternity care needs improvement, healthtech can help

pharmaphorum

Improving maternity care is crucial, and healthtech innovations can play a significant role in enhancing maternal health outcomes. Explore how technology can revolutionise maternal care.

115
115
article thumbnail

Telepharmacy Empowers Pharmacists Practicing in a Changing Landscape

Drug Topics

Telepharmacy can empower pharmacists to practice at the top of their license, fostering a more efficient and accessible health care system that benefits both patients and providers.

112
112
article thumbnail

Marea’s $190m double round heads latest biotech financings

pharmaphorum

Marea Therapeutics raises $190m for cardiometabolic pipeline, with Santa Ana Bio, Opthea, InduPro, Elion, and iOnctura also completing rounds

111
111
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Is MiraLAX safe for cats?

The Checkup by Singlecare

Just like their owners, our furry friends can become constipated. If your cat is straining to go, you may be surprised to learn that MiraLAX, an over-the-counter (OTC) medication taken by humans, can also work for cats. Keep reading to learn everything you need to know about giving your cat MiraLAX to help with feline constipation. RELATED: Save up to 80% on MiraLAX What is MiraLAX used for in cats?

Dosage 105
article thumbnail

Third fire at Novo Nordisk, but company says there’s no link

pharmaphorum

Novo Nordisk has been affected by a third fire in a month, the latest involving an office building near its Copenhagen headquarters.

110
110
article thumbnail

Pharma Pulse 6/19/24: DIA 2024 Coverage, How Orange Peels Connect to Heart Health & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

104
104
article thumbnail

Sobi gets EU okay for long-acting haemophilia A drug

pharmaphorum

Sobi’s long-acting rVIII drug Altuvoct has been cleared for haemophilia A in the EU, with a label that spans all ages and any disease severity.

Labelling 105
article thumbnail

OTC Product Roundup: Digestive Health

Drug Topics

Struggling with gas, bloating, diarrhea, or other stomach issues? Don’t let digestive discomfort hold your patients back—check out these OTC products to get them feeling their best again.

98
article thumbnail

ASCO 2024 - Henar Hevia and Carolyn Sousa

pharmaphorum

Watch the exclusive interview with Henar Hevia and Carolyn Sousa at ASCO 2024 as they discuss the latest advancements in cancer research and treatment. Get insights and updates in this informative video.

100
100
article thumbnail

Non-chemotherapy lymphoma treatment may provide durable remission

European Pharmaceutical Review

A non-chemotherapy multi-drug therapy enabled complete remission in 38 percent of evaluable patients with aggressive B-cell lymphoma, a Phase Ib/II clinical trial shows. This was observed in individuals who had experienced a return of their cancer or who were unresponsive to standard treatments. Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) were used together in a treatment regimen in 50 patients with diffuse large B-cell lymphoma (DLBCL).

article thumbnail

Multiple Vitamin Deficiencies Associated with Worse Migraine Outcomes

Drug Topics

A poster presented at AHS 2024 found that older patients tended to have more vitamin deficiencies compared to younger patients.

94
article thumbnail

Mainz Biomed CEO discusses stool test for colorectal cancer vs Galleri blood test

Outsourcing Pharma

Catching cancer early can save lives because it can be treated before it spreads in the body.

91
article thumbnail

Does Chocolate Trigger Migraines?

Drug Topics

Shivang Joshi, MD, MPH, RPh, FAHS, headache specialist neurologist at Community Neuroscience Services, debunks common migraine myths.

86
article thumbnail

AI and real-world data integration: Transforming clinical trials and drug development - panel at DIA Global

Outsourcing Pharma

During a panel discussion held at DIA Global in San Diego this week, which was moderated by Peter Wahl, industry experts delved into the integration of real-world (RW) data and advanced technologies to accelerate drug development.

85
article thumbnail

FDA: Exblifep Approved for Complicated Urinary Tract Infections

Drug Topics

Cefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation.

FDA 86
article thumbnail

Looking Ahead to Cardinal Health's Biosimilar Pipeline

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses what to expect from Cardinal Health's biosimilars pipeline.

80
article thumbnail

IBI-343 by Innovent Biologics for Solid Tumor: Likelihood of Approval

Pharmaceutical Technology

IBI-343 is under clinical development by Innovent Biologics and currently in Phase I for Solid Tumor.

75
article thumbnail

The Role of the Planetary Health Diet in Combating Chronic Diseases, Climate Change

Pharmacy Times

Adopting the Planetary Health Diet may reduce overall risk of chronic disease and premature death.

73